Results 41 to 50 of about 8,541 (190)

Comparison of Krypton and Argon Laser Photocoagulation

open access: yes, 1984
• We compared the clinical and histological effects of argon blue-green laser (ABGL), argon green laser (AGL), and krypton red laser (KRL) photocoagulation on the primate retina.
Smiddy, William E   +5 more
core   +1 more source

Current and new concepts in the diagnosis and management of diabetic macular oedema [PDF]

open access: yes, 2013
Diabetic macular oedema, which can cause rapid visual deterioration, may not have early warning signs at times. Assessment of diabetic retinal complications is made chiefly by clinical examination combined with optical coherence tomography (OCT) and ...
Jyothi, Sreedhar
core   +2 more sources

Experience with 808-nm diode laser in the treatment of 47 cases of oral vascular anomalies

open access: yesBrazilian Oral Research
Treatment of oral vascular anomalies (OVA) has focused on minimally invasive techniques rather than radical surgery. We investigated the efficacy and safety of diode laser using the photocoagulation technique in the management of OVA.
Fernanda Vieira HEIMLICH   +9 more
doaj   +1 more source

A Case of Presumed Dyskeratosis Congenita Causing Severe Retinal Vascular Occlusion

open access: yesCase Reports in Ophthalmology, 2021
Dyskeratosis congenita (DKC) is a rare, multisystem, bone marrow failure disease characterized by abnormalities such as in the skin, mucosa, nervous system, and lungs.
Takahisa Hirokawa   +7 more
doaj   +1 more source

Training and validation of an automated algorithm to differentiate no and minimal diabetic retinopathy from more severe stages in wide‐field images

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose Diabetic retinopathy (DR) is a leading cause of blindness in the working‐age population. Screening is essential to identify and treat sight‐threatening stages prior to irreversible visual loss. This study aimed to train and validate an automated algorithm to identify no or minimal DR, potentially saving resources for specialist ...
Lars Morten Skollerud   +4 more
wiley   +1 more source

In vivo and in vitro photocoagulation.

open access: yes, 2013
Representative images showing: A) Pale dots (white arrows) in the upper right portion of the field observed shortly after exposure to the laser (spot size = 500 µm).
Lisa M. Berglund (417793)   +4 more
core   +1 more source

The impact of coronary artery bypass grafting on the short‐ and long‐term development and progression of diabetic retinopathy: A Danish national matched cohort study

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose Diabetic retinopathy (DR) is a frequent long‐term complication of diabetes. While hemodynamic changes are known risk factors for DR, the effect of coronary artery bypass grafting (CABG) on the development of DR is poorly investigated.
Lukas Greve Maschoreck   +16 more
wiley   +1 more source

Diode laser photocoagulation of choroidal hemangioma

open access: yes, 1995
Background: The argon laser photocoagulation has recently become the treatment of choice in choroidal hemangioma. We evaluated the efficacy of the near infrared wavelength diode laser in the treatment of such tumours.
Menchini U.   +5 more
core   +1 more source

Intravitreal anti-VEGF agents, oral glucocorticoids, and laser photocoagulation combination therapy for macular edema secondary to retinal vein occlusion: preliminary report [PDF]

open access: yesInternational Journal of Ophthalmology, 2018
AIM: To evaluate the efficacy and safety of combined anti-vascular endothelial growth factor (VEGF) agents, oral glucocorticoid, and laser photocoagulation therapy for macular edema (ME) secondary to retinal vein occlusion (RVO).
Xiao-Xiao Feng   +7 more
doaj   +1 more source

Advanced Coats' disease: Treating the effect before the cause

open access: yesOman Journal of Ophthalmology, 2022
An 8-year-old child with Stage 3A Coats' disease and severe submacular lipid exudation was initially treated with intravitreal injections of bevacizumab followed by triamcinolone.
Dhananjay Shukla
doaj   +1 more source

Home - About - Disclaimer - Privacy